(JREG) JPMorgan s (Ireland) ICAV - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BF4G6Y48 • Global Large-Cap Blend Equity
JREG: Global, Equities, Stocks, Companies, Portfolio, Investments
The objective of the JPMorgan ETF (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF is to deliver long-term returns exceeding its benchmark by actively investing in a global portfolio of companies. The fund is listed on XETRA under the ticker symbol JREG and is classified as a Global Large-Cap Blend Equity ETF. It tracks the Morningstar Global TSM NR USD Index and is designed for investors seeking exposure to large-cap companies worldwide. For more information, visit http://www.jpmorganassetmanagement.com.
Based on the provided data, the fund currently has an AUM of 234.41M EUR, with an average daily trading volume of 17,967 shares. The last price recorded is 49.27, with key technical indicators showing an SMA20 of 50.08, SMA50 of 49.64, and SMA200 of 46.61. The ATR is 0.47, indicating moderate volatility. Over the next three months, the fund is expected to maintain its upward trajectory, supported by its strong AUM and low volatility. The SMA20 and SMA200 suggest a bullish outlook, with potential price targets approaching the SMA50 level. Investors can anticipate stable performance, consistent with its large-cap blend strategy.
Additional Sources for JREG ETF
JREG ETF Overview
| Market Cap in USD | 266m |
| Category | Global Large-Cap Blend Equity |
| IPO / Inception | 2018-10-10 |
JREG ETF Ratings
| Growth Rating | 73.1 |
| Fundamental | - |
| Dividend Rating | 0.0 |
| Rel. Strength | -7.6 |
| Analysts | - |
| Fair Price Momentum | 39.43 EUR |
| Fair Price DCF | - |
JREG Dividends
No Dividends PaidJREG Growth Ratios
| Growth Correlation 3m | -88.1% |
| Growth Correlation 12m | 54% |
| Growth Correlation 5y | 92.7% |
| CAGR 5y | 13.32% |
| CAGR/Max DD 5y | 0.62 |
| Sharpe Ratio 12m | 1.12 |
| Alpha | -7.53 |
| Beta | 0.748 |
| Volatility | 33.92% |
| Current Volume | 11k |
| Average Volume 20d | 35.6k |
As of April 25, 2025, the stock is trading at EUR 42.79 with a total of 10,983 shares traded.
Over the past week, the price has changed by +3.12%, over one month by -9.01%, over three months by -14.23% and over the past year by +1.37%.
Yes. Based on ValueRay Analyses, JPMorgan s (Ireland) ICAV (XETRA:JREG) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.10 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JREG as of April 2025 is 39.43. This means that JREG is currently overvalued and has a potential downside of -7.85%.
JPMorgan s (Ireland) ICAV has no consensus analysts rating.
According to ValueRays Forecast Model, JREG JPMorgan s (Ireland) ICAV will be worth about 43.9 in April 2026. The stock is currently trading at 42.79. This means that the stock has a potential upside of +2.48%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 43.9 | 2.5% |